December 20, 2023
The University of Cincinnati's Francisco Romo-Nava published research in the journal Molecular Psychiatry that found noninvasive spinal cord stimulation is safe and has therapeutic potential to treat depression.
January 12, 2024
University of Cincinnati research on how eating strawberries can reduce dementia risk was featured in a "LIVE with Kelly and Mark" segment on superfoods to eat in 2024.
October 23, 2023
The American Cancer Society has awarded the University of Cincinnati Cancer Center a $360,000 Institutional Research Grant that will provide pilot grant support for early-stage investigators working in cancer-related fields.
March 4, 2024
A clinical trial led by University of Cincinnati researchers at the Lindner Center of HOPE found the drug liraglutide was safe and effective for weight loss for patients with stable bipolar disorder.
May 3, 2024
The University of Cincinnati's Robert Cohen spoke with Local 12 about the GRADE study that shows how a new medication needs to be developed to help treat people with type two diabetes.
May 23, 2024
Interesting Engineering and Drug Target Review highlighted research led by University of Cincinnati and Cincinnati Children's Hospital researcher Ziyuan Guo that developed the first human mini-brain that incorporates a fully functional blood-brain barrier.
January 11, 2021
COVID-19 vaccine providers across Ohio will soon get better guidance about the next steps for getting shots into arms. Brett Kissela, MD, spoke to WLWT-TV, Channel 5 and said the benefits of the vaccine outweigh any potential side effects.
September 21, 2022
UC is one of 36 sites part of the GRADE study comparing different diabetes medicines. The study is going to be published in the New England Journal of Medicine.
October 6, 2022
The University of Cincinnati is committing $12 million to grow inclusive excellence by leveraging diverse perspectives to advance innovation, creativity and complex problem solving in biomedical research. The new program, FIRST+ Lives Here for Urban Health, aligns with the National Institutes of Health’s FIRST (Faculty Institutional Recruitment for Sustainable Transformation) Program and advances the university’s Next Lives Here strategic direction.
October 17, 2022
Treatments for pulmonary arterial hypertension (PAH) — a type of high blood pressure that affects arteries in the lungs and in the heart — have improved significantly over the past 15 to 20 years and researchers at the University of Cincinnati have been at the forefront of those improvements. The result of a series of studies UC researchers were part of have allowed new medications to come to market for patients with PAH.